The role of complement in nonalcoholic fatty liver disease

The role of complement in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic liver diseases globally. NAFLD includes a range of hepatic manifestations, starting with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis, cirrhosis or even hepatocellular carcinoma. Although...

Full description

Bibliographic Details
Main Authors: Zhenya Guo, Xiude Fan, Jianni Yao, Stephen Tomlinson, Guandou Yuan, Songqing He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
complement system
nonalcoholic fatty liver disease
site-targeted inhibitor
inflammation
liver
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017467/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017467/full

Similar Items